Europe Bone Cement Market Report and Forecast 2024-2032

Europe Bone Cement Market Report and Forecast 2024-2032

Market Outlook

According to the report the Europe bone cement market grew significantly in 2023. Aided by the surging orthopaedic surgical procedures and a steadily ageing populace, the market is projected to further grow at a CAGR of 5.7% between 2024 and 2032 a value of about USD 329.55 million by 2032..

Bone cement, primarily utilised in orthopaedic interventions, serves as an anchoring substance bridging the gap between the prosthesis and the bone. Its prominent usage is observed in arthroplasty, particularly in surgeries related to hip and knee replacements. Given its adhesive capabilities, bone cement assures that artificial components adhere securely, providing post-operative stability and manoeuvrability.

A significant driver for the Europe bone cement market growth trajectory is the heightened incidence of conditions like osteoporosis and osteoarthritis. As Europe homes a notable fraction of the world’s elderly, there's been a conspicuous uptick in bone-related ailments, consequently driving a pronounced demand for bone cement, given the increase in joint replacements.

Furthermore, Europe's intrinsic love for sports and regular physical activities has occasionally led to sports-related injuries, necessitating surgical repairs. As bone cement is indispensable in ensuring the success of many such interventions, Europe bone cement market demand has seen substantial growth.

Medical advancements haven't left bone cement untouched. The proliferation of minimally invasive surgeries (MIS) in Europe, celebrated for their shorter recovery durations and diminished post-operative distress, often necessitate the use of bone cement, thereby amplifying its demand.

Beyond orthopaedics, the dental sector in Europe is seeing a burgeoning utilisation of bone cement. With cosmetic dentistry on the rise, procedures like dental implants and other reconstructions heavily rely on the cement for prolonged stability, thus influencing the Europe bone cement market outlook.

The sophisticated healthcare ecosystem in Europe, coupled with significant healthcare investments, further propels the bone cement market. Pioneering research in the region has introduced avant-garde bone cements with superior biocompatibility and quicker setting times. These innovations ensure not only enhanced patient experiences but also buttress the overall growth of the bone cement market.

As per the Europe bone cement market analysis, the demand for the product is not confined merely to healthcare. Academic institutions are probing into its potential uses in arenas outside the medical domain. Preliminary explorations indicate a possible application in sectors like civil engineering, thanks to its unique adhesive attributes. Although still embryonic, these investigations provide a glimpse into a diversified horizon for bone cement in Europe.

Market Segmentation

The market can be divided based on product, application, end use, and region.

Market Breakup by Product

• Calcium Phosphate Cement (CPC)
• Glass Polyalkenoate Cement
• Polymethyl Methacrylate (PMMA) Cement

Market Breakup by Application

• Kyphoplasty
• Arthroplasty
• Vertebroplasty

Market Breakup by End Use

• Hospital
• Ambulatory Surgical Centres
• Clinics

Market Breakup by Country

• United Kingdom
• Germany
• France
• Italy
• Others

Competitive Landscape

The report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the Europe bone cement market. Some of the major players explored in the report are as follows:

• Johnson & Johnson MedTech (Depuy Synthes)
• Stryker Corporation
• Zimmer Biomet Holdings, Inc
• Smith & Nephew plc
• Medtronic plc
• Arthrex, Inc.
• Cardinal Health, Inc.
• Heraeus Medical LLC
• Teknimed
• LABORATORIOS SL S.A.
• Others